Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duchenne muscular dystrophy steroid regimen trial
ISRCTN46102316Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of prednisone and deflazacort in Duchenne muscular dystrophy (DMD), sponsored by University of Rochester. Primary endpoint: Primary multivariate outcome. Started Nov 2012; status: completed.
02
Drugs
prednisonedeflazacort
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on ISRCTN46102316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46102316.